Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Saudi Arabian Oil Company › 18194849
Last updated: May 29, 2026
Application No. 18/194,849

PROCESSING WATER FROM HYDROCARBON OPERATIONS

Final Rejection
Filed
Apr 03, 2023
Examiner
BARHAM, BETHANY P
Art Unit
1611
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Saudi Arabian Oil Company
OA Round
2 (Final)
52%
Grant Probability
Moderate
3-4
OA Rounds
8m
Est. Remaining
84%
With Interview

This examiner grants 52% of cases after interview

— +32.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.
Based on 510 resolved cases, 2023–2026

Examiner Intelligence

BARHAM, BETHANY P View full profile →
Grants 52% of resolved cases
52%
Career Allowance Rate
263 granted / 510 resolved
-8.4% vs TC avg
Strong +32% interview lift
Without
With
+32.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
10 currently pending
Career history
524
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
79.5%
+39.5% vs TC avg
§102
8.0%
-32.0% vs TC avg
§112
4.3%
-35.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 510 resolved cases

Prosecution Timeline

Apr 03, 2023
Application Filed
May 29, 2025
Non-Final Rejection mailed
Jul 08, 2025
Response Filed
Sep 08, 2025
Final Rejection mailed
Sep 23, 2025
Interview Requested
Apr 13, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

18/130,583
Patent 12622943
COMPOSITION FOR RELIEVING WOMAN MENOPAUSAL SYMPTOM COMPRISING A MIXED EXTRACT OF HOP AND CITRUS PEEL AND METHOD FOR TREATING OR ALLEVIATING MENOPAUSAL SYMPTOM USING THE SAME
3y 1m to grant Granted May 12, 2026
18/136,103
Patent 12622866
TOPICAL COMPOSITIONS AND METHODS
3y 0m to grant Granted May 12, 2026
18/322,693
Patent 12616659
THERAPEUTIC AGENT NANOPARTICLES AND METHODS OF PREPARATION
2y 11m to grant Granted May 05, 2026
18/277,701
Patent 12605358
COMPOSITION FOR PREVENTING OR TREATING NERVOUS SYSTEM DISEASES COMPRISING COMPOUND THAT INHIBITS MTOR SIGNALING PATHWAY AS ACTIVE INGREDIENT
2y 8m to grant Granted Apr 21, 2026
18/616,227
Patent 12599586
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
2y 0m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
52%
Grant Probability
84%
With Interview (+32.2%)
3y 10m (~8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 510 resolved cases by this examiner. Grant probability derived from career allowance rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month